Unsure which funding opportunity is right for you? Use our investor matching tool to help you on to your next step
Find investorsTakes less than ~2 min to complete
We are a Copenhagen based venture capital company, investing in outstanding ICT companies with proof of product, 1st. class management and scalable business models. We work actively to ignite and enhance growth within our portfolio companies - through business development, internationalization and acquisitions Over the last 10 years we have executed more than 40 investment cycles, transforming companies – and eventually exited our investments through trade sales or market listings.
2015 Member of Keystones Aps 2015 Member of DanBan 2015 Pharma/Medico consultant 2014 Manager, LEO Pharma, CMO Management 2011 Director, LEO Pharma, External Manufacturing 2007 Senior consultant, NNE Pharmaplan 1996 Site VP, Novo Nordisk A/S, Maaloev 1989 VP, Novo Nordisk A/S, Biopha. Production 1987 Section manager, Nordisk Gentofte, Insulin prod. Section 1978 Head of department, Nordisk Gentofte, Purification 1974 Research assistant, The James F. Mitchell Foundation Washington D.C.
Urbantech is a non-equity, pilot-focused innovation program founded in Denmark in 2019. The program works in tailored processes with growth-stage startups creating solutions in urban technology. By collaborating with the program’s corporate partners, Urbantech’s startups will be able to develop their businesses, improve their value proposition - and increase their ability to fundraise further. Selected startups receive a €15K grant to cover travel and other expenditures.
We like to get in early, probably at the stage where your business is still an idea or at least pre-seed. The core values that we bring to the table is Decades of experience and deep technical expertise, perhaps to build the first version (Beta), or take your beta to the next level. We can also together with like-minded Angel investors or VC´s bring the first capital needed to launch your products and get the first paying customers.